glp-1 employer healthcare costs GLP-1s driving cost hikes, employers say Perspectives from Employers on the

The presence of GLP-1 (GLP-1R) and GIP receptors (GIP-R) suggest direct interaction of these agents with EAT

The employers winning this arent the ones who simply cover the drug

doi: 10.3389/fphar.2023.1303844 Received 28 September 2023 Accepted 30 November 2023 Published 11 December 2023 Volume 14 - 2023 Edited by Alessio Squassina, University of Cagliari, Italy Reviewed by Michele Mazzanti, University of Milan, Italy Yashmin Choudhury, Assam University, India Updates Copyright 2023 Greco, Coperchini, Croce, Magri, Teliti and Rotondi

, ,

1 : 88100 Cullis PR, DeKruijff B

The only intellectually honest comparisons are the ones the evidence actually supports